SearchSearch result list

Please understand that carbon ion radiotherapy indication requires to meet the following common condition.
■The cancer lesion is limited, not be extensive
■Radiation therapy was not performed on the target cancer lesion.
■Patient can lie down with rest for about 30 minutes.
■PS (Performance Status) at the moment of the treatment start is 0-2 (K160 over).
■No active and intractable inflammation exists in the expecting irradiation area.
■The patient accepted the cancer diagnosis and would like to take heavy iron therapy of his/her own will.
General evaluation by specialists is required to decide the indication for carbon ion radiotherapy. There is a case to be out of the indication for carbon ion therapy after reviewing the patient’s condition (cancer board).

Our premium package offers comprehensive diagnostics, including FDG-PET/CT scans, blood tests, electrocardiograms, and ultrasound exams. Experienced doctors, trained at university hospitals, meticulously review your test results to offer precise and personalized guidance.

The department specialises in the endoscopic diagnosis and treatment of tumours of the digestive tract (oesophagus, stomach, duodenum and large intestine).

In particular, the accuracy of endoscopic diagnosis of early-stage tumours and treatment techniques using mucosal resection and submucosal dissection are among the best in Japan.

The Department specialises in malignant tumours of the digestive system and boasts the highest number of cases and treatment results in Japan, particularly for oesophageal cancer, oesophagogastric junction cancer, gastric cancer, colorectal cancer, hepatocellular cancer, bile duct cancer, gallbladder cancer, metastatic liver cancer and pancreatic cancer.

For advanced cancers, we offer multidisciplinary treatment using a combination of chemotherapy + perioperative chemotherapy such as molecular-targeted drugs + immune checkpoint inhibitors.

The department specialises in the treatment of urological malignancies, including surgery, radiotherapy, chemotherapy and immunotherapy. The department is one of the leading departments in Japan for the treatment of urological malignancies.

"We specialize in treating cancers of the liver, bile ducts, and pancreas (the hepatobiliary-pancreatic region). Our number of tests, procedures, and treatments is among the highest in Japan."

We strive to cure blood cancers and complex blood diseases with the best and most advanced treatments. With our 33-bed sterile ward, we specialise in chemotherapy, haematopoietic cell transplants, and immuno-cell therapy for blood cancers. We also offer consultations in English.

We provide surgical treatment for primary lung cancer, metastatic lung tumours and mediastinal tumours. We are also actively involved in multidisciplinary treatment of these cancers.

Our treatment results for primary lung cancer are among the best in Japan. Our priority is to cure lung cancer.

Our goal in breast cancer treatment is to provide the best treatment for you, using a variety of oncoplastic surgical techniques, endocrine therapy, chemotherapy, molecular targeted therapy and radiotherapy. We are a team of breast cancer treatment specialists who are committed to providing you with the best possible support.